Holen Sie sich die Stockscreener-App
5.41%
Handel nachbörslich:
Schlusskurs vom Vortag:
$0.5597
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.40M
Einnahmen:
$98,000
Nettoeinkommen (Verlust:
$-86.59M
KGV:
0.00
EPS:
-5.45
Netto-Cashflow:
$-48.49M
1W Leistung:
+5.41%
1M Leistung:
-72.17%
6M Leistung:
-91.22%
1J Leistung:
-95.66%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.4204
$0.64
52-Wochen-Spanne:
$0.4204
$0.64
Stock (BIOR) Company Profile
Firmenname
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BIOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIOR
Biora Therapeutics Inc
|
0.00 | 2.40M | 98,000 | -86.59M | -48.49M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.27 | 104.37B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.13 | 78.59B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
628.32 | 37.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.26 | 31.25B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.51 | 27.21B | 3.30B | -501.07M | 1.03B | -2.1146 |
Aktie (BIOR) Neueste Nachrichten
Biora Therapeutics to be delisted from Nasdaq By Investing.com - Investing.com Canada
Biora Therapeutics to be delisted from Nasdaq - Investing.com
Why Biora Therapeutics (BIOR) Stock Is Down 45% - Benzinga
Dow Falls 150 Points; Oracle Posts Downbeat Results - Benzinga
Biora Therapeutics Reports Q3 2024 Results and Updates - TipRanks
Biora Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Highbridge Capital Management's Strategic Acquisition of Biora T - GuruFocus.com
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire
Biora Therapeutics Advances BioJet Device, Cuts Monthly Expenses 40% Amid Q3 Loss | BIOR Stock News - StockTitan
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
S&P 500 price target raised at Oppenheimer after 'decisive' election results - Investing.com
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewswire
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SEC Form 424B5 filed by Biora Therapeutics Inc. - Quantisnow
SEC Form 424B3 filed by Biora Therapeutics Inc. - Quantisnow
Biora Therapeutics announces $3 million stock and warrant sale - Investing.com India
Biora Therapeutics advances oral drug delivery tech By Investing.com - Investing.com Nigeria
Biora Therapeutics advances oral drug delivery tech - Investing.com India
Biora Therapeutics Shares Progress on Smaller BioJet™ - GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - StockTitan
Progenity Inc stock hits 52-week high of $5.2 amid market fluctuations - Investing.com
Biora Therapeutics Inc’s results are impressive - US Post News
Market Highlights: Biora Therapeutics Inc (BIOR) Ends on a Low Note at 0.55 - The Dwinnex
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting - The Manila Times
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the - GlobeNewswire
Biora Therapeutics enacts reverse stock split, adjusts shares By Investing.com - Investing.com Australia
Biora Therapeutics enacts reverse stock split, adjusts shares - Investing.com India
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium - The Manila Times
Biora Therapeutics Announces Award-Winning Abstract to be - GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - Yahoo Finance
Biora Therapeutics Inc’s Market Journey: Closing Weak at 0.59, Down -9.63 - The Dwinnex
Biora Therapeutics Inc Inc. (BIOR) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Biora Therapeutics secures additional $4 million financing - Investing.com India
Biora Therapeutics secures additional $4 million financing By Investing.com - Investing.com UK
Biora Therapeutics Achieves ISO 13485 Certification - GlobeNewswire
A History of Outperforming Analyst Forecasts and Beating the Odds: Biora Therapeutics Inc (BIOR) - SETE News
Biora Therapeutics Announces Positive Nasdaq Listing Decision - GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Biora Therapeutics secures new financial agreements - Investing.com India
Finanzdaten der -Aktie (BIOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
3.68%
Kapitalisierung:
|
Volumen (24h):